Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-03-01 4:10 pm Sale | 13D | LANTERN PHARMA INC LTRN | Bios Equity Partners LP | 1,263,802 11.8% | -202,889 (-13.83%) | View |
| 2023-12-01 06:02 am Sale | 13D | LANTERN PHARMA INC LTRN | Bios Equity Partners LP | 1,466,691 13.6% | -508,150 (-25.73%) | View |
| 2023-07-03 3:04 pm Purchase | 13D | AZITRA INC AZTR | Bios Equity Partners LP | 6,961,041 56.9% | 6,961,041 (New Position) | View |
| 2022-03-22 4:15 pm Purchase | 13D | LANTERN PHARMA INC LTRN | Bios Equity Partners LP | 1,974,841 18.1% | 5,855 (+0.30%) | View |
| 2020-06-23 3:17 pm Purchase | 13D | LANTERN PHARMA INC LTRN | Bios Equity Partners LP | 1,968,986 30.6% | 1,968,986 (New Position) | View |